Share on LinkedInShare on LinkedIn

ARTICLE · 08 NOVEMBER 2026

New York DOL Proposes Regulations Implementing Workplace Opioid Antagonist Requirements

New York State has proposed detailed regulations for implementing workplace opioid antagonist requirements that take effect in December 2026. The regulations address critical questions about how many doses employers must maintain, where they should be placed, who needs training, and how shared workplaces can coordinate compliance. Covered employers face a tight timeline to assess their obligations and prepare for enforcement under these new workplace safety standards.

United StatesEmployment and HR

Seyfarth Synopsis:The New York State Department of Labor has proposed regulations providing details on New York’s new workplace opioid antagonist (e.g., naloxone or Narcan) requirements, which take effect December 13, 2026. The proposed regulations address the number and placement of opioid antagonists, employee training, maintenance requirements, and shared workplaces, while preserving the law’s existing coverage threshold.

As discussed in our prior alert and blog post, New York enacted a law in December 2025 requiring certain private employers to have an opioid antagonist, such as naloxone or Narcan, available for use in providing first aid or emergency treatment at the workplace. A February 2026 amendment clarified the law and directed the New York State Department of Labor (“NYSDOL”), in coordination with the Department of Health, to issue implementing regulations.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from